IFRX•benzinga•
InflaRx Halts Vilobelimab Phase 3 Trial In Pyoderma Gangrenosum After Futility Finding In Interim Analysis
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 28, 2025 by benzinga